Acute complications in sickle cell disease;Complications aiguës de la drépanocytose

Revue du Praticien

Volumn 54, Issue 14, 2004, Pages 1548-1556

  Habibi, Anoosha ^b   Bachir, Dora ^b   Godeau, Bertrand ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ARGININE; CORTICOSTEROID; ETAFEDRINE; FOLIC ACID DERIVATIVE; HYDROXYUREA; KETOPROFEN; MORPHINE; NALOXONE; NEFOPAM; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ABDOMINAL PAIN; ACIDOSIS; ACUTE CHEST SYNDROME; ANTIBIOTIC THERAPY; ARTHRALGIA; BLOOD TRANSFUSION; BLOOD VESSEL OCCLUSION; BONE NECROSIS; BONE PAIN; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CHRONIC RESPIRATORY FAILURE; CONGESTIVE CARDIOMYOPATHY; DEHYDRATION; FEVER; GLOMERULOPATHY; HEMOCHROMATOSIS; HOSPITAL ADMISSION; HUMAN; HYPOXEMIA; KIDNEY FAILURE; KIDNEY TUBULE DISORDER; MULTIPLE ORGAN FAILURE; OXYGEN THERAPY; PRIAPISM; PULMONARY HYPERTENSION; RETINOPATHY; REVIEW; SICKLE CELL ANEMIA; VESTIBULAR DISORDER;

ACUTE DISEASE; ANEMIA, SICKLE CELL; ARTERIAL OCCLUSIVE DISEASES; BLOOD TRANSFUSION; HUMANS; MULTIPLE ORGAN FAILURE; PAIN; SYNDROME;

EID: 4744353105     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Sarjeant GR. Sickle cell disease. Lancet 1997; 350: 725-30.
2. Bunn HF. Pathogenesis and treatement of sickle cell disease. N Engl J Med 1997; 337: 762-9.
3. Galactéros F. Drépanocytose: physiopathologie et diagnostic. Rev Prat 1995; 45: 351-60.
4. Girot R, Bégué P, Galactéros F. La drépanocytose. Montrouge: John Libbey. 2003.
5. Platt. O, Branbilla DJ, Rosse WF et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994; 330: 1639-44.
6. Couttant-Perronne V, Roberts-Harewood M, Bachir D et al. Patterns of ortality in sickle cell disease in adults in Europe. Submitted.
7. Hassell KL, Eckmann JR, Lane PA. Acute multiorgan failure syndrome: a potentially catstrophic complication of severe sickle cell pain episodes. Am J Med 1994; 96: 155-62.
8. Habibi A, Brun-Buisson C, Bachir D, Schaeffer A, Galactéros F, Godeau B. Drépanocytose vue à l'âge adulte et réanimation. Reanimation 2002; 11: 317-25.
9. Langlade A. Analgésie contrôlée par le patient: bénéfices, risques, modalités de surveillance. Ann Fr Anesth Reanim 1998; 17: 585-98.
10. Bachir D, Bonnet-Gajdos N, Galacteros F. La transfusion dans la drépanocytose. Presse Med 1990; 27: 19: 1627-3.
11. Maitre B, Habibi A, Roudot-Thoraval F et al. Acute chest syndrome in adults with sickle cell disease: therapeutic approach, outcome and results of bronchoalveolar lavage in a monocentric series of 107 episodes. Chest 2000; 117: 1386-92.
12. Vichinski E, Neumayr L, Earles A et al. for the National Acute chest Study group. Causes and outcomes of the acute chest syndrome in sickle cell disease. N Engl J Med 2000; 342: 1855-65.
13. Kirkpatrick M, Haynes J, Bass JB. Results of bronchoscopically obtained lower airway cultures from adult sickle cell disease patients with the acute chest syndrome. Am J Med 1991; 90: 206-10.
14. Solanki DL, Kletter GG, Castro O. Acute splenic sequestration crises in adults with sickle cell disease. Am J Med 1986; 80: 985-90.
15. Serjeant GR, Sarjesnt BE, Thomas PW, Anderson NJ, Patou G, Pattison JR. Human parvovirus infection in homozygous sickle cell disease. Lancet 1993; 341: 1237-40.
16. Godeau B, Bachir D, Randrianjohany A et al. Nécrose médullaire extensive et syndromes drépanocytaires majeurs. Rev Med Interne 1994; 15: 25-9.
17. Ohsne-Frempong K, Weiner SJ, Sleeper LA et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998; 91: 288-94.
18. Bachir D, Virag R, Lee K et al. Prévention et traitement des troubles érectiles de la drépanocytose. Rev Med Interne 1997; 18: 46s-51s.